DE60041582D1 - Verfahren zum nachweis ungenügender bindung von magnesium an zelluläre membranen zum krankheitsnachweis - Google Patents

Verfahren zum nachweis ungenügender bindung von magnesium an zelluläre membranen zum krankheitsnachweis

Info

Publication number
DE60041582D1
DE60041582D1 DE60041582T DE60041582T DE60041582D1 DE 60041582 D1 DE60041582 D1 DE 60041582D1 DE 60041582 T DE60041582 T DE 60041582T DE 60041582 T DE60041582 T DE 60041582T DE 60041582 D1 DE60041582 D1 DE 60041582D1
Authority
DE
Germany
Prior art keywords
magnesium
cellular membranes
disease identification
insufficient binding
detecting insufficient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60041582T
Other languages
English (en)
Inventor
Ibert C Wells
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Magnesium Diagnostics Inc
Original Assignee
Magnesium Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magnesium Diagnostics Inc filed Critical Magnesium Diagnostics Inc
Application granted granted Critical
Publication of DE60041582D1 publication Critical patent/DE60041582D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/321—Arterial hypertension

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60041582T 1999-03-10 2000-03-09 Verfahren zum nachweis ungenügender bindung von magnesium an zelluläre membranen zum krankheitsnachweis Expired - Fee Related DE60041582D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/265,690 US6372440B2 (en) 1999-03-10 1999-03-10 Method for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses
PCT/US2000/003707 WO2000054053A1 (en) 1999-03-10 2000-03-09 Method for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses

Publications (1)

Publication Number Publication Date
DE60041582D1 true DE60041582D1 (de) 2009-04-02

Family

ID=23011495

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60041582T Expired - Fee Related DE60041582D1 (de) 1999-03-10 2000-03-09 Verfahren zum nachweis ungenügender bindung von magnesium an zelluläre membranen zum krankheitsnachweis

Country Status (7)

Country Link
US (3) US6372440B2 (de)
EP (1) EP1181554B1 (de)
AT (1) ATE423316T1 (de)
AU (1) AU4000400A (de)
CA (1) CA2365666A1 (de)
DE (1) DE60041582D1 (de)
WO (1) WO2000054053A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040171093A1 (en) * 1999-03-10 2004-09-02 Wells Ibert C. Methods for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses
US6455734B1 (en) 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
US7838245B2 (en) * 2004-04-20 2010-11-23 Sphingotec Gmbh Use of precursors of tachykinins and/or their fragments in medical diagnostic
US7678444B2 (en) * 2007-12-17 2010-03-16 International Paper Company Thermoformed article made from renewable polymer and heat-resistant polymer
US20090274920A1 (en) * 2008-05-05 2009-11-05 International Paper Company Thermoformed Article Made From Bio-Based Biodegradable Polymer Composition
WO2011071666A1 (en) * 2009-12-08 2011-06-16 International Paper Company Thermoformed articles made from reactive extrusion products of biobased materials
WO2015009970A1 (en) 2013-07-18 2015-01-22 Erythron Llc Spectroscopic measurements with parallel array detector
US20150338338A1 (en) 2014-02-28 2015-11-26 Erythron, Llc Method and Apparatus for Determining Markers of Health by Analysis of Blood
WO2016168090A1 (en) 2015-04-14 2016-10-20 Nueon, Inc. Method and apparatus for determining markers of health by analysis of blood
WO2017165403A1 (en) 2016-03-21 2017-09-28 Nueon Inc. Porous mesh spectrometry methods and apparatus
WO2018085699A1 (en) 2016-11-04 2018-05-11 Nueon Inc. Combination blood lancet and analyzer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3894995A (en) * 1972-12-26 1975-07-15 Hoechst Ag Transparent polyamides from an isomeric mixture of norbornanes
US4144244A (en) * 1977-12-27 1979-03-13 Ciba-Geigy Corporation Perfluoroalkyl-iodo norbornane dicarboxylic acids and derivatives thereof
US4331570A (en) * 1980-07-17 1982-05-25 International Flavors & Fragrances Inc. Carboamidoalkyl norbornanes and organoleptic use in perfumes
DE3401949A1 (de) * 1984-01-20 1985-08-01 Bayer Ag, 5090 Leverkusen Norbornan- und norbornencarbonsaeureamide, verfahren zu deren herstellung sowie die verwendung von norbornan- und norbornencarbonsaeureamiden als arzneimittel
US4705897A (en) * 1986-05-05 1987-11-10 Texaco Inc. Process for producing bicyclic diamines
GB8613431D0 (en) 1986-06-03 1986-07-09 Medical Res Council Human tachykinins
US5616562A (en) 1990-04-27 1997-04-01 Murphy; Christopher J. Methods and compositions using substance P to promote wound healing
FR2677362B1 (fr) * 1991-06-04 1995-04-28 Centre Nat Rech Scient Neuropeptides de la famille des tachykinines.
ATE197793T1 (de) 1992-08-13 2000-12-15 Warner Lambert Co Tachykinin antagonistes
US6403577B1 (en) 1993-11-17 2002-06-11 Eli Lilly And Company Hexamethyleneiminyl tachykinin receptor antagonists
US5492927A (en) 1993-12-21 1996-02-20 Eli Lilly And Company Non-peptide tachykinin receptor antagonists to treat allergy
ITFI940009A1 (it) 1994-01-19 1995-07-19 Menarini Farma Ind Antagonisti delle tachichinine, loro preparazione e formulazioni farmaceutiche che li contengono.
CA2187531A1 (en) 1994-06-06 1995-12-14 David Christopher Horwell Tachykinin (nk1) receptor antagonists
US5491140A (en) 1994-06-30 1996-02-13 Eli Lilly And Company Naphthyl tachykinin receptor antagonists to treat physiological conditions
US5607947A (en) 1995-02-21 1997-03-04 Eli Lilly And Company Pyrrolidinyl tachykinin receptor antagonists
US5563133A (en) 1995-02-21 1996-10-08 Eli Lilly And Company Hexamethyleneiminyl tachykinin receptor antagonists
US5565568A (en) 1995-04-06 1996-10-15 Eli Lilly And Company 2-acylaminopropanamides as tachykinin receptor antagonists
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
US20040171093A1 (en) * 1999-03-10 2004-09-02 Wells Ibert C. Methods for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses

Also Published As

Publication number Publication date
WO2000054053A9 (en) 2001-10-11
CA2365666A1 (en) 2000-09-14
EP1181554A1 (de) 2002-02-27
US20010051345A1 (en) 2001-12-13
ATE423316T1 (de) 2009-03-15
EP1181554B1 (de) 2009-02-18
US6372440B2 (en) 2002-04-16
AU4000400A (en) 2000-09-28
EP1181554A4 (de) 2002-11-06
US20030077658A1 (en) 2003-04-24
US20070134738A1 (en) 2007-06-14
WO2000054053A1 (en) 2000-09-14

Similar Documents

Publication Publication Date Title
WO2004092199A3 (en) Method for identifying modulators of g protein coupled receptor signaling
ATE321088T1 (de) Polysiloxanpolymere, verfahren zu ihrer herstellung und ihre verwendung
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
WO2005047470A3 (en) Intercalator fret donors or acceptors
DE60335733D1 (de) Verfahren zur solubilisierung von protein
DE60041582D1 (de) Verfahren zum nachweis ungenügender bindung von magnesium an zelluläre membranen zum krankheitsnachweis
ATE352784T1 (de) Verfahren zum screenen für gpr40-liganden
ATE376997T1 (de) Verfahren zur herstellung von 1,4- diphenylazetidinon-derivaten
IL200120A0 (en) Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes
DE502005000428D1 (de) Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen
WO2005000875A3 (en) Compositions and methods comprising a ligand of chemerin receptor
WO2006079334A3 (de) Verfahren zu nachweis und quantifizierung von proteinen unter verwendung von farbstoffen auf der basis von polymethinen
DE69902796D1 (de) Verfahren zur reinigung von biomolekül- oder proteinkomplexen
WO2010079076A3 (de) Autosomal dominante polyzystische nierenerkrankung (adpkd)
WO2005018552A3 (en) Heparin binding proteins: sensors for heparin detection
ATE347698T1 (de) Verfahren zum nachweis von alzheimer-krankheit
DE60336822D1 (de) Verfahren zur herstellung von kristallinem 1,2-polybutadien
ATE370411T1 (de) Verfahren zum screening
WO2004090164A3 (en) Method for determining soil condition
DE60216416D1 (de) Verfahren zum nachweis von chloralhydrat in dichloressigsäure
ATE310734T1 (de) Verfahren zur herstellung von n-substituierten 2, 6-dialkylmorpholinen
WO2005111075A3 (en) CRYSTAL STRUCTURE OF FACTOR VAi AND METHOD FOR IDENTIFYING BLOOD FACTOR Va MODULATORS
DE502004004068D1 (de) Einrichtung zum Bergen von unter Wasser befindlichen Fremdteilen
ATE286037T1 (de) Verfahren zur herstellung von 5-substituierten isobenzofuranen
DE602004016006D1 (de) Screening-verfahren

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee